ZYME Q4 2025 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-91.9% YoY

Gross Profit

$824,00032.8% margin

Operating Income

-$44M-1755.5% margin

Net Income

-$41M-1638.5% margin

EPS (Diluted)

$-0.55

QoQ Revenue Growth

-90.9%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$18.9B

Stock-Based Comp.

-$3.4B

Balance Sheet

Total Assets

$347M

Total Liabilities

$78M

Stockholders' Equity

$269M

Cash & Equivalents

$41.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$31M	-91.9%
Gross Profit	$824,000	$31M	-97.3%
Operating Income	-$44M	-$22M	-98.7%
Net Income	-$41M	-$24M	-75.3%

Revenue Segments

Upfront Fee

$18M100%